Olivotto I - Search Results

1

Role of Exercise Testing in Hypertrophic Cardiomyopathy.

Rowin EJ, Maron BJ, Olivotto I, Maron MS. Rowin EJ, et al. Among authors: olivotto i. JACC Cardiovasc Imaging. 2017 Nov;10(11):1374-1386. doi: 10.1016/j.jcmg.2017.07.016. JACC Cardiovasc Imaging. 2017. PMID: 29122139 Free article. Review.

2

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Cecchi F, et al. Among authors: olivotto i. J Am Coll Cardiol. 1995 Nov 15;26(6):1529-36. doi: 10.1016/0735-1097(95)00353-3. J Am Coll Cardiol. 1995. PMID: 7594081 Free article.

3

Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration.

Cecchi F, Montereggi A, Olivotto I, Marconi P, Dolara A, Maron BJ. Cecchi F, et al. Among authors: olivotto i. Heart. 1997 Jul;78(1):44-9. doi: 10.1136/hrt.78.1.44. Heart. 1997. PMID: 9290401 Free PMC article.

4

Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.

Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Cecchi F, et al. Among authors: olivotto i. Heart. 1998 Apr;79(4):331-6. doi: 10.1136/hrt.79.4.331. Heart. 1998. PMID: 9616338 Free PMC article.

5

Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy.

Olivotto I, Montereggi A, Mazzuoli F, Cecchi F. Olivotto I, et al. G Ital Cardiol. 1999 Jan;29(1):11-9. G Ital Cardiol. 1999. PMID: 9987042

6

Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy.

Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F. Olivotto I, et al. J Am Coll Cardiol. 1999 Jun;33(7):2044-51. doi: 10.1016/s0735-1097(99)00094-7. J Am Coll Cardiol. 1999. PMID: 10362212 Free article.

7

Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F. Maron BJ, et al. Among authors: olivotto i. Circulation. 2000 Aug 22;102(8):858-64. doi: 10.1161/01.cir.102.8.858. Circulation. 2000. PMID: 10952953

8

Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy.

Olivotto I, Maron BJ, Cecchi F. Olivotto I, et al. Curr Cardiol Rep. 2001 Mar;3(2):141-6. doi: 10.1007/s11886-001-0041-x. Curr Cardiol Rep. 2001. PMID: 11177672 Review.

9

Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.

Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Olivotto I, et al. Circulation. 2001 Nov 20;104(21):2517-24. doi: 10.1161/hc4601.097997. Circulation. 2001. PMID: 11714644

10

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.

Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP, Casey SA, Gohman TE, Bongioanni S, Spirito P. Maron BJ, et al. Among authors: olivotto i. J Am Coll Cardiol. 2002 Jan 16;39(2):301-7. doi: 10.1016/s0735-1097(01)01727-2. J Am Coll Cardiol. 2002. PMID: 11788223 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

804 results

Search Page

Filters